Image Up Advertising & Design

Mission Statement The Yucaipa Valley Chamber of Commerce is dedicated to promoting a vibrant business environment by cooperative interaction among business, government and community For more information, call (909) 790-1841 • Fax (909) 363-7373 35139 Yucaipa Blvd., Yucaipa, CA 92399 info@yucaipachamber.org 2016 Board of Directors Chairperson, Lynette Alvarado Wildwood Canyon Villa Past Chair, Nancy Kenny Homestreet Bank Chair Elect, Michelle Riggs Crafton Hills College Finance Vice-Chair, John Hopkins Prospect Financial Solutions Directors Cheryl Benton Cheryl & Co Cali Binks Yucaipa Calimesa Joint Unified School District Jeff Dewan Edward Jones Financial Advisors Jo-Ann Forsyth Forsyth & Associate Insurance Valerie Menefee State Farm Insurance CHAMBER STAFF Amy Minjares, President/CEO Ellen Benefiel, Membership Development Coordinator AMBASSADOR TEAM Cheryl Benton, Cheryl & Co. Cali Binks, Yucaipa Calimesa JUSD Pamela Brierly-Vengarick, Good Nite Inn Gene & Jo-Ann Forsyth, Forsyth & Associates Insurance Brandy Gomez, Law Office of Linda Roberts-Ross John Hopkins, Prospect Financial Solutions Susie Jarvis, Alta Vista Credit Union Nancy Kenny, Homestreet Bank Kimberly Mackamul, Big Mikes' Rooter & Plumbing Danielle Marrufo, Century 21 Lois Lauer Dora Ordonez, Asaderos Supermarket William Ziprick, Ziprick & Cramer, LL Linda Witham, Yucaipa Rotary Club 20 OUR YUCAIPA | JULY 2016 Message from the Chairperson By Lynette Alvarado Alzheimer's Association celebrates extraordinary week during "Alzheimer and Brain Awareness Month" Today, the Senate Appropriations Committee approved a $400 million increase in Alzheimer's disease research funding at the NIH and included the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act (S. 857) in its funding bill. The Alzheimer's Association applauds the committee for this momentous action in the journey to end the Alzheimer's epidemic — and in improving support for those who face the disease today. "Today, Alzheimer's disease is the only leading cause of death in the U.S. without a way to prevent, cure or even slow its progression," said Harry Johns, Alzheimer's Association president and CEO. "However, because of the bipartisan leadership that was demonstrated by the Senate Appropriations committee this week, the lives of those who have Alzheimer's, as well as their caregivers will be improved and we are a significant step closer to a world without Alzheimer's." At a cost of $236 billion each year, Alzheimer's is the most expensive disease in the nation. Yet, today it receives only $991 million in NIH research funding, even following a nearly 60 percent increase last year. Leading experts have stated that a ramp up to at least $2 billion a year is necessary to meet the first goal of the National Plan to Address Alzheimer's Disease. Appropriations Subcommittee Chairman Roy Blunt (R-Mo.) and Ranking Member Patty Murray (D-Wash.) were instrumental in securing bipartisan support for the largest-ever increase in Alzheimer's disease research funding at the NIH for the second year. "Senators Blunt and Murray, as well as the full Appropriations Committee, understand the physical, emotional and financial impact that this devastating and fatal disease has on millions of Americans," said Robert Egge, chief public policy officer of the Alzheimer's Association. "Their continued commitment to advance research and improve care and support for America's most expensive disease is transforming our nation's fight against Alzheimer's and related dementias." If signed into law, the HOPE for Alzheimer's Act will ensure newly diagnosed Medicare beneficiaries receive comprehensive care planning services. Alzheimer's Association grassroots advocates and staff held thousands of congressional meetings to secure support for the HOPE for Alzheimer's Act since the bill's introduction, and have worked tirelessly to secure support for increased funding for NIH research. Alzheimer's Association celebrates extraordinary week during Alzheimer & Brain Awareness Month

• Cover